On Tuesday, Yum Foods announced that it would be spinning off its China food business as a separate franchise by the end of next year. Nation’s Restaurant News said the spin-off would entail separating the operations of the Chinese restaurants. Yum China would then be operating as a publicly-traded firm and would have to pay a percentage of its sales from using the company’s brands, namely KFC, Pizza Hut and Taco Bell, Reuters reported.
Following the separation, each standalone company will be able to intensify focus on its distinct commercial priorities, allocate its own resources to meet the needs of its business, and pursue distinct capital structures and capital allocation strategies. This will provide a clear investment thesis and visibility to attract long-term investor base suited to each business,” CEO of Yum Brands Greg Creed said in a statement.
USA Today said the announcement followed the pressure Yum has received from its activist investors, which no doubt had been concerned about the backlash it received from its involvement in a couple of food safety scares and its disappointing third-quarter earnings report released earlier this month.


Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 



